On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2016: Volume 21/ Issue 4 Article 7
Back to Table of Contents

Eurosurveillance, Volume 21, Issue 4, 28 January 2016
Weidmann: Addendum for Euro Surveill. 2015;20(44)

+ Author affiliations

Citation style for this article: Weidmann M. Addendum for Euro Surveill. 2015;20(44). Euro Surveill. 2016;21(4):pii=30121. DOI:

Received:28 January 2016; Accepted:28 January 2016

For the article ‘Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015’ (, by Faye et al., published on 05 November 2015, the authors would like to add that the World Health Organisation (WHO)-approved RealStar Filovirus Screen RT-PCR Kit 1.0 (Altona Diagnostics, Hamburg, Germany) has been widely used on Smart Cyclers throughout the Ebola outbreak in West Africa, although the manufacturer does not list this device in their instructions for use. The company published a note on its website on 10 July 2015 (, commenting the reported lack of sensitivity of this kit when used on a Smart Cycler. According to our findings, we consider that the reported lack of sensitivity is related to the restriction of using the kit for specific PCR cyclers only, as also found by other groups [1] previously.


  1. Janvier F, Sagui E, Foissaud V. ReEBOV Antigen Rapid Test kit for Ebola.Lancet. 2015;386(10010):2254-5. DOI: 10.1016/S0140-6736(15)01107-1 PMID: 26681288

Back to Table of Contents

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.